EMA review finds AstraZeneca benefits still outweigh risks
AFP, 23 Apr 2021
The deputy executive director of EU's drug watchdog says during a press conference that a review of AstraZeneca's Covid-19 vaccine found its benefits still outweigh the risks for adults despite links to blood clots. SOUNDBITE
Subscribe to AFP and activate your notifications to get the latest news 🔔
http://www.youtube.com/channel/UC86dbj-lbDks_hZ5gRKL49Q/?sub_confirmation=1